Perinatal outcomes in type 2 diabetes

Niranjala M Hewapathirana, Helen R Murphy

Research output: Contribution to journalArticlepeer-review


Over the past decade the prevalence of type 2 diabetes in pregnancy has continued to increase. It is vital that health care professionals recognize that preconception care is just as important for mothers with type 2 diabetes as it is in type 1 diabetes. All women with type 2 diabetes should be advised regarding safe effective contraception and the benefits of optimal glycemic control, folic acid supplementation, and avoidance of potentially harmful mediations before attempting pregnancy. Glycemic control is the most important modifiable risk factor for congenital anomaly in women with type 2 diabetes, whereas maternal obesity and social disadvantage are associated with large for gestational age neonates. This review aims to bring the reader up to date with the burden of perinatal outcomes and clinical interventions to improve maternal and infant health. It warns that the consequences of type 2 diabetes pregnancy do not end at birth.

Original languageEnglish
Article number461
JournalCurrent Diabetes Reports
Early online date7 Jan 2014
Publication statusPublished - Feb 2014


  • Blood Congenital malformation
  • Large for gestational age
  • Macrosomia
  • Perinatal mortality
  • Stillbirth
  • Neonatal mortality
  • Type 2 diabetes

Cite this